Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Seattle Biomedical Research Institute" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Seattle Biomedical Research Institute for you to read. Along with our medical data and news we also list Seattle Biomedical Research Institute Clinical Trials, which are updated daily. BioPortfolio also has a large database of Seattle Biomedical Research Institute Companies for you to search.
(Texas Biomedical Research Institute) Texas Biomedical Research Institute and The Children's Hospital of San Antonio have joined forces to cure a mysterious condition called Kawasaki disease. The illness which affects young children is named after the Japanese doctor who first described it more than 50 years ago.
(Texas Biomedical Research Institute) During the West African Ebola outbreak that began in 2013, an experimental biopharmaceutical drug called ZMappTM was a glimmer of hope in the midst of a health crisis. Now, scientists at Texas Biomedical Research Institute in San Antonio have been awarded a $2 million dollar contract by the makers of ZMapp, Mapp Biopharmaceutical, Inc., to further test this pr...
Centerline Biomedical, Inc. was founded in 2014 as a spinoff of the Cleveland Clinic to commercialize their innovative vascular navigation technology. With a research, development, and design history rooted in the Clinic’s world-class Lerner Research Institute’s Heart and Vascular Institute, the IOPS™ platform can be further used for predictive modeling, clinical decision support, global hea...
(Louisiana State University) A research team at LSU's Pennington Biomedical Research Center has been approved for a five-year, $4.5 million funding award by the Patient-Centered Outcomes Research Institute, or PCORI, to evaluate two treatments for children who have obesity.
(Texas Biomedical Research Institute) Promising experimental cancer chemotherapy drugs may help knock out another life-threatening disease: tuberculosis (TB). A new study published by scientists at Texas Biomedical Research Institute in San Antonio pinpoints a mechanism in regulating cell death called apoptosis that is a potential new target for helping to control the bacterial infection (Mycobact...
Lon Cardon, GSK, and John Stamatoyannopoulos, University of Washington, discuss the recent launch of Altius Institute for Biomedical Sciences. Funded by GSK, Altius is an independent non-profit research institute focused on genomic research.
A research team at LSU's Pennington Biomedical Research Center has been approved for a five-year, $4.5 million funding award by the Patient-Centered Outcomes Research Institute, or PCORI, to evaluate two treatments for children who have obesity.
New research underway at Seattle Children’s Research Institute could pave the way for a rapid screening test capable of diagnosing submicroscopic infections
Seattle TimesScientist behind Dolly the cloned sheep, a key to Parkinson's research, has disease himselfSeattle TimesSeven-month-old Dolly, the genetically cloned sheep, looks towards the camera at the Roslin Institute Tuesday, Feb. 25, 1997. It was revealed Tuesday that Dolly, the first animal to be genetically cloned from adult cells, got her name from Country ...Parkinson's Pioneer Dr. Ian Wilm...
So, what’s it like for a city’s downtown workers to forego the car and utilize other means in terms of satisfying or fulfilling duties? Just ask Seattle, Washington, the Pacific Northwest-located city. Commute Seattle in a 2014 “Downtown Seattle Commuter Trends” press release reported, “[m]ore people are commuting to Downtown Seattle than ever, but the […]
(The Translational Genomics Research Institute) A Norwegian biotech company called Phoenix Solutions AS is working with the Translational Genomics Research Institute (TGen), a Phoenix, Arizona-based biomedical research facility, to test the use of these pulsed sound waves to direct and focus cancer drug therapies.
In recent weeks, the firearms controversy has again lit up the media in the United States, with clarification that anyone engaged in the business of selling firearms must get a license and conduct background checks. But, argues Fred Rivara from the Seattle Children’s Research Institute and Harborview Injury Prevention and Research Center, we may...
Like a good cup of coffee, Seattle’s life sciences ecosystem is a balanced blend of complementary parts: research to find the underpinnings of disease, and information technology that helps scientists make sense of the data. That convergence was on display last week at Xconomy’s annual What’s Hot in Seattle Biotech event. Here are a few […]
(NIH/National Institute of Allergy and Infectious Diseases) A more intensive biomedical research approach is necessary to control and ultimately eliminate tuberculosis (TB), according to a perspective published in The American Journal of Tropical Medicine and Hygiene. In the article, authors Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, and Robert W...
The Minister of State for Health and Social Care responds to biomedical research question.
On January 31, two Seattle biotech companies, Seattle Genetics and Cascadian Therapeutics, announced a merger agreement under which Seattle Genetics will acquire Cascadian Therapeutics for $614 million.  The announcement catapulted Cascadian Therapeutics shares to a 16-month high, and a 69% increase over the previous day's closing price.
Xconomy’s annual Seattle-area life sciences conference will be held on June 12 at Cambia Grove in the Emerald City’s downtown. “What’s Hot in Seattle Biotech” will look at what’s hot, and what’s next, for the Puget Sound region’s life sciences scene. It’s only March , but already this year, Seattle’s life science community has seen […]
att BOTHELL, Wash. & SEATTLE–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) and Cascadian Therapeutics, Inc. (Nasdaq:CASC) today announced the signing of a definitive merger agreement under which Seattle Genetics has agreed to acquire Cascadian Therapeutics. Under the terms of the agreement, Seattle Genetics will pay $10.00 per share in cash, or approximately $614 million. T...
SEATTLE - April 19, 2018 (Investorideas.com Newswire) Eden Labs, Inc. will host an exclusive Seattle premiere screening of the feature-length film, Mary Janes: The Women of Weed in The Seattle Art Museum Plestcheeff Auditorium at 6:30 PM on May 15, 2018.
On the24 thofApril, John Boesche, vice president of Visit Seattle International Tourism and Marcus Carney, tourism manager of Visit Seattle, Read more...
A wide array of institutions, attractions, and exhibits are part of this offer including the Seattle Art Museum, Tacoma Art Museum, Seattle Children's Museum, Museum Read more...
PolarityTE, (NASDAQ:COOL) announced the acquisition of a preclinical biomedical research facility in order to accelerate research and development of PolarityTE pipeline products. The facility is an already fully-functional, operational and profitable contract research organization (CRO) which is regulated and compliant under both Good Laboratory Practices (GLP) and United States Department of Agri...
SEATTLE, April 24, 2018/PRNewswire/ -- The Personalized Lifestyle Medicine Institute (PLMI) will host the Sixth Annual Thought Leaders Consortium Oct. 12-13, 2018at the Read more...
Madrid (ots/PRNewswire) - PharmaMar (MCE: PHM) hat heute die Unterzeichnung einer exklusiven Lizenzvereinbarung mit Seattle Genetics Inc. (SGEN: NASDAQ GS) bekanntgegeben, nach der Seattle Genetics...
Seattle Genetics Inc. agreed to pay $614mm ($10 per share in cash, a 107% premium) to acquire fellow Seattle-based cancer bio...